Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Atar

Showing results (331-340 of 405) with videos related to

Pageof 41
Sort By:
European Heart Journal|September 19, 2008
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)Kenneth Dickstein, Alain Cohen-Solal, Gerasimos Filippatos, et al.
European Journal of Heart Failure|October 2, 2008
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)Kenneth Dickstein, Alain Cohen-Solal, Gerasimos Filippatos, et al.
European Heart Journal|December 28, 2017
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registryFreek W A Verheugt, Haiyan Gao, Wael Al Mahmeed, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 5, 2024
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on ThrombosisBruna Gigante, Juan Tamargo, Stefan Agewall, et al.
Journal of Electrocardiology|November 7, 2017
Appropriateness of anteroseptal myocardial infarction nomenclature evaluated by late gadolinium enhancement cardiovascular magnetic resonance imagingJoseph Allencherril, Yama Fakhri, Henrik Engblom, et al.
European Heart Journal|December 26, 2015
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on ThrombosisAlexander Niessner, Juan Tamargo, João Morais, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trialJustin A Ezekowitz, Basil S Lewis, Renato D Lopes, et al.
Clinical Chemistry|December 3, 2014
Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudyZiad Hijazi, Agneta Siegbahn, Ulrika Andersson, et al.
European Heart Journal|February 6, 2016
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2Hans-Christoph Diener, James Aisenberg, Jack Ansell, et al.
European Heart Journal|February 6, 2016
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1Hans-Christoph Diener, James Aisenberg, Jack Ansell, et al.
Pageof 41

Showing results (331-340 of 405) with videos related to

Sort By:
Pageof 41
European Heart Journal|September 19, 2008
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)Kenneth Dickstein, Alain Cohen-Solal, Gerasimos Filippatos, et al.
European Journal of Heart Failure|October 2, 2008
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)Kenneth Dickstein, Alain Cohen-Solal, Gerasimos Filippatos, et al.
European Heart Journal|December 28, 2017
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registryFreek W A Verheugt, Haiyan Gao, Wael Al Mahmeed, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 5, 2024
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on ThrombosisBruna Gigante, Juan Tamargo, Stefan Agewall, et al.
Journal of Electrocardiology|November 7, 2017
Appropriateness of anteroseptal myocardial infarction nomenclature evaluated by late gadolinium enhancement cardiovascular magnetic resonance imagingJoseph Allencherril, Yama Fakhri, Henrik Engblom, et al.
European Heart Journal|December 26, 2015
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on ThrombosisAlexander Niessner, Juan Tamargo, João Morais, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trialJustin A Ezekowitz, Basil S Lewis, Renato D Lopes, et al.
Clinical Chemistry|December 3, 2014
Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudyZiad Hijazi, Agneta Siegbahn, Ulrika Andersson, et al.
European Heart Journal|February 6, 2016
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2Hans-Christoph Diener, James Aisenberg, Jack Ansell, et al.
European Heart Journal|February 6, 2016
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1Hans-Christoph Diener, James Aisenberg, Jack Ansell, et al.
Pageof 41